Zelira Therapeutics Ltd

Zelira Therapeutics Ltd is a biopharmaceutical company engaged in the research, development, and commercialization of cannabinoid-based medicines. Focused on providing treatment solutions for chronic conditions and unmet medical needs, the company leverages a science-backed approach to develop novel therapeutic products. Targeting industries spanning pharmaceuticals and healthcare, Zelira Therapeutics Ltd primarily operates within the globally expanding medicinal cannabis sector. With a strong emphasis on clinical trials and regulatory approvals, the company ensures that its products meet high standards of efficacy and safety. Zelira Therapeutics Ltd maintains a strategic presence in key markets, enhancing its influence and contributing to the broader acceptance and integration of cannabis-derived treatments in traditional medical frameworks.